{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:33:58Z","timestamp":1767598438022,"version":"3.44.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005725","name":"National Plan for Science, Technology and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004919","name":"King Abdulaziz City for Science and Technology","doi-asserted-by":"publisher","award":["12-MED3221-02"],"award-info":[{"award-number":["12-MED3221-02"]}],"id":[{"id":"10.13039\/501100004919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejphar.2020.173656","type":"journal-article","created":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T09:43:06Z","timestamp":1603014186000},"page":"173656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Renin-angiotensin system at the interface of COVID-19 infection"],"prefix":"10.1016","volume":"890","author":[{"given":"Rukhsana","family":"Gul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uh-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assim A.","family":"Alfadda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173656_bib1","article-title":"Counter-regulatory 'renin-angiotensin' system-based candidate drugs to treat COVID-19 diseases in SARS-CoV-2-infected patients","author":"Annweiler","year":"2020","journal-title":"Infect. Disord. - Drug Targets"},{"key":"10.1016\/j.ejphar.2020.173656_bib2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/SHK.0b013e318228f614","article-title":"The Angiotensin-converting enzyme inhibitor captopril inhibits poly(adp-ribose) polymerase activation and exerts beneficial effects in an ovine model of burn and smoke injury","volume":"36","author":"Asmussen","year":"2011","journal-title":"Shock"},{"key":"10.1016\/j.ejphar.2020.173656_bib3","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1073\/pnas.0809524106","article-title":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites","volume":"106","author":"Belouzard","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2020.173656_bib4","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1001\/jama.2020.8707","article-title":"Nasal gene expression of angiotensin-converting enzyme 2 in children and adults","volume":"323","author":"Bunyavanich","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.ejphar.2020.173656_bib5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","article-title":"Myocardial infarction increases ACE2 expression in rat and humans","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2020.173656_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41421-020-0147-1","article-title":"Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations","volume":"6","author":"Cao","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.ejphar.2020.173656_bib7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/1440-1681.12059","article-title":"Role of angiotensin AT(2) receptors in natriuresis: intrarenal mechanisms and therapeutic potential","volume":"40","author":"Carey","year":"2013","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2020.173656_bib8","doi-asserted-by":"crossref","first-page":"H137","DOI":"10.1152\/ajpheart.00618.2015","article-title":"Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?","volume":"310","author":"Chappell","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2020.173656_bib9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s11033-013-2920-9","article-title":"Losartan attenuates microvascular permeability in mechanical ventilator-induced lung injury in diabetic mice","volume":"41","author":"Chen","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejphar.2020.173656_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2020.173656_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejphar.2020.173656_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0065-3527(05)64006-7","article-title":"Molecular interactions in the assembly of coronaviruses","volume":"64","author":"de Haan","year":"2005","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.ejphar.2020.173656_bib13","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejphar.2020.173656_bib14","doi-asserted-by":"crossref","first-page":"33678","DOI":"10.1038\/srep33678","article-title":"Neprilysin is a mediator of alternative renin-angiotensin-system Activation in the murine and human kidney","volume":"6","author":"Domenig","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173656_bib15","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2020.173656_bib16","first-page":"e35","article-title":"Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis","volume":"8","author":"Emami","year":"2020","journal-title":"Arch Acad Emerg Med."},{"key":"10.1016\/j.ejphar.2020.173656_bib17","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jacc.2008.02.088","article-title":"Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system","volume":"52","author":"Epelman","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2020.173656_bib18","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0002-9343(76)90889-5","article-title":"Conversion of angiotensin I to angiotensin II","volume":"60","author":"Erd\u00f6s","year":"1976","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2020.173656_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2020.173656_bib20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/HYPERTENSIONAHA.109.145839","article-title":"New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism","volume":"55","author":"Ferrario","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2020.173656_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MNH.0b013e3283406f57","article-title":"ACE2: more of Ang-(1-7) or less Ang II?","volume":"20","author":"Ferrario","year":"2011","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.ejphar.2020.173656_bib22","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2020.173656_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/HYPERTENSIONAHA.109.140145","article-title":"Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases","volume":"55","author":"Ferreira","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2020.173656_bib24","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2020.173656_bib25","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2020.173656_bib26","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2353\/ajpath.2007.061088","article-title":"Pathology and pathogenesis of severe acute respiratory syndrome","volume":"170","author":"Gu","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2020.173656_bib27","first-page":"1861","article-title":"Clinical characteristics of covid-19 in China. Reply","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2020.173656_bib28","doi-asserted-by":"crossref","first-page":"H77","DOI":"10.1152\/ajpheart.01355.2007","article-title":"A novel signaling pathway of ADP-ribosyl cyclase activation by angiotensin II in adult rat cardiomyocytes","volume":"295","author":"Gul","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2020.173656_bib29","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/oby.21227","article-title":"Regulation of cardiac miR-208a, an inducer of obesity, by rapamycin and nebivolol","volume":"23","author":"Gul","year":"2015","journal-title":"Obesity"},{"key":"10.1016\/j.ejphar.2020.173656_bib30","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/cvr\/cvn232","article-title":"Inhibition of ADP-ribosyl cyclase attenuates angiotensin II-induced cardiac hypertrophy","volume":"81","author":"Gul","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2020.173656_bib31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000343456","article-title":"RAS-mediated adaptive mechanisms in cardiovascular tissues: confounding factors of RAS blockade therapy and alternative approaches","volume":"2","author":"Gul","year":"2012","journal-title":"Cardiorenal Med."},{"key":"10.1016\/j.ejphar.2020.173656_bib32","doi-asserted-by":"crossref","first-page":"H901","DOI":"10.1152\/ajpheart.00250.2011","article-title":"Cooperative interaction between reactive oxygen species and Ca2+ signals contributes to angiotensin II-induced hypertrophy in adult rat cardiomyocytes","volume":"302","author":"Gul","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2020.173656_bib33","volume":"9","author":"Guo","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.ejphar.2020.173656_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","author":"Gurwitz","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejphar.2020.173656_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.2162","article-title":"The emerging role of ACE2 in physiology and disease","volume":"212","author":"Hamming","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejphar.2020.173656_bib36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jinf.2020.02.010","article-title":"Coronavirus 2019-nCoV: a brief perspective from the front line","volume":"80","author":"Han","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.ejphar.2020.173656_bib37","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40262-013-0072-7","article-title":"Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects","volume":"52","author":"Haschke","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2020.173656_bib38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2020.173656_bib39","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bbrc.2004.05.114","article-title":"Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor","volume":"319","author":"Hofmann","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2020.173656_bib40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/SHK.0000000000001382","article-title":"Preadmission antihypertensive drug use and sepsis outcome: impact of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs)","volume":"53","author":"Hsieh","year":"2020","journal-title":"Shock"},{"key":"10.1016\/j.ejphar.2020.173656_bib41","doi-asserted-by":"crossref","first-page":"H1013","DOI":"10.1152\/ajpheart.00068.2005","article-title":"Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats","volume":"289","author":"Igase","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2020.173656_bib42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.173656_bib43","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2020.173656_bib44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/SHK.0000000000000633","article-title":"Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease","volume":"46","author":"Jia","year":"2016","journal-title":"Shock"},{"key":"10.1016\/j.ejphar.2020.173656_bib45","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.chembiol.2004.07.013","article-title":"Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics","volume":"11","author":"Kao","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejphar.2020.173656_bib46","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1161\/CIRCHEARTFAILURE.108.840124","article-title":"Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction","volume":"2","author":"Kassiri","year":"2009","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.ejphar.2020.173656_bib47","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","article-title":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome","volume":"21","author":"Khan","year":"2017","journal-title":"Crit. Care."},{"key":"10.1016\/j.ejphar.2020.173656_bib48","doi-asserted-by":"crossref","first-page":"m406","DOI":"10.1136\/bmj.m406","article-title":"Response to the emerging novel coronavirus outbreak","volume":"368","author":"Kickbusch","year":"2020","journal-title":"Bmj"},{"key":"10.1016\/j.ejphar.2020.173656_bib49","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4266\/kjccm.2016.00976","article-title":"Effect of renin-angiotensin system blockage in patients with acute respiratory distress syndrome: a retrospective case control study","volume":"32","author":"Kim","year":"2017","journal-title":"Korean J Crit Care Med."},{"key":"10.1016\/j.ejphar.2020.173656_bib50","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature17200","article-title":"Pre-fusion structure of a human coronavirus spike protein","volume":"531","author":"Kirchdoerfer","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.173656_bib51","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","article-title":"A novel coronavirus associated with severe acute respiratory syndrome","volume":"348","author":"Ksiazek","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2020.173656_bib52","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2020.173656_bib53","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00109-006-0094-9","article-title":"Lessons from SARS: control of acute lung failure by the SARS receptor ACE2","volume":"84","author":"Kuba","year":"2006","journal-title":"J. Mol. Med. (Berl)."},{"key":"10.1016\/j.ejphar.2020.173656_bib54","first-page":"Iv7","article-title":"Tissue renin-angiotensin systems. Their role in cardiovascular disease","volume":"87","author":"Lee","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2020.173656_bib55","article-title":"Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig","author":"Lei","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.ejphar.2020.173656_bib56","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1113\/expphysiol.2007.040352","article-title":"Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor","volume":"93","author":"Lew","year":"2008","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ejphar.2020.173656_bib57","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"An Rev Virol."},{"key":"10.1016\/j.ejphar.2020.173656_bib58","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2020.173656_bib59","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.173656_bib60","doi-asserted-by":"crossref","first-page":"L178","DOI":"10.1152\/ajplung.00009.2008","article-title":"Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis","volume":"295","author":"Li","year":"2008","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ejphar.2020.173656_bib61","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.ejphar.2020.173656_bib62","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/HYPERTENSIONAHA.117.09600","article-title":"Deletion of angiotensin-converting enzyme-2 promotes hypertensive nephropathy by targeting Smad 7 for ubiquitin degradation","volume":"70","author":"Liu","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2020.173656_bib63","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2020.173656_bib64","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00109-002-0334-6","article-title":"Tissue renin-angiotensin system and end-organ damage","volume":"80","author":"Luft","year":"2002","journal-title":"J. Mol. Med. (Berl)."},{"key":"10.1016\/j.ejphar.2020.173656_bib65","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3390\/v6082991","article-title":"The coronavirus nucleocapsid is a multifunctional protein","volume":"6","author":"McBride","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.ejphar.2020.173656_bib66","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.ejphar.2020.173656_bib67","first-page":"1474","article-title":"Angiotensin-converting enzyme inhibitors in hypertension","volume":"71","author":"Messerli","year":"2018","journal-title":"To Use or Not to Use?"},{"key":"10.1016\/j.ejphar.2020.173656_bib68","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2020.173656_bib69","doi-asserted-by":"crossref","first-page":"10628","DOI":"10.1128\/JVI.78.19.10628-10635.2004","article-title":"Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2","volume":"78","author":"Moore","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2020.173656_bib70","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1592\/phco.27.12.1619","article-title":"Impact of previous statin and angiotensin II receptor blocker use on mortality in patients hospitalized with sepsis","volume":"27","author":"Mortensen","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2020.173656_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17070797","article-title":"Role of the renin-angiotensin-aldosterone system beyond blood pressure regulation: molecular and cellular mechanisms involved in end-organ damage during arterial hypertension","volume":"17","author":"Mu\u00f1oz-Durango","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2020.173656_bib72","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1586\/17446651.2014.956723","article-title":"Renin-angiotensin-aldosterone system and the aging kidney","volume":"9","author":"Musso","year":"2014","journal-title":"Expet Rev. Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2020.173656_bib73","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1128\/JVI.74.17.8127-8134.2000","article-title":"Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells","volume":"74","author":"Narayanan","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2020.173656_bib74","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/01.HYP.0000237862.94083.45","article-title":"Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat","volume":"48","author":"Ocaranza","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2020.173656_bib75","doi-asserted-by":"crossref","first-page":"594361","DOI":"10.1155\/2012\/594361","article-title":"Protective role of the ACE2\/ang-(1-9) Axis in cardiovascular remodeling","volume":"2012","author":"Ocaranza","year":"2012","journal-title":"Int. J. Hypertens."},{"key":"10.1016\/j.ejphar.2020.173656_bib76","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1050-1738(02)00233-5","article-title":"The role of ACE2 in cardiovascular physiology","volume":"13","author":"Oudit","year":"2003","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2020.173656_bib77","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","article-title":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","volume":"39","author":"Oudit","year":"2009","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2020.173656_bib78","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2337\/db09-1218","article-title":"Human recombinant ACE2 reduces the progression of diabetic nephropathy","volume":"59","author":"Oudit","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2020.173656_bib79","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00424-012-1146-3","article-title":"AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function","volume":"465","author":"Padia","year":"2013","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.ejphar.2020.173656_bib80","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fmed.2020.00335","article-title":"ACE\/ACE2 ratio: a key also in 2019 coronavirus disease (Covid-19)?","volume":"7","author":"Pagliaro","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.ejphar.2020.173656_bib81","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/s41401-020-0430-6","article-title":"Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication","volume":"41","author":"Pang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2020.173656_bib82","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ACE2\/angiotensin 1-7 Axis of the renin-angiotensin system in heart failure","volume":"118","author":"Patel","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2020.173656_bib83","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1161\/CIRCULATIONAHA.120.047297","article-title":"Substituting angiotensin-(1-7) to prevent lung damage in SARS-CoV-2 infection?","volume":"141","author":"Peir\u00f3","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2020.173656_bib84","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1055\/s-0030-1255680","article-title":"[Acute respiratory insufficiency due to severe lung injury - ARDS and ALI]","volume":"64","author":"Pfeifer","year":"2010","journal-title":"Pneumologie"},{"key":"10.1016\/j.ejphar.2020.173656_bib85","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/01.HYP.0000244543.91937.79","article-title":"Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study","volume":"48","author":"Rice","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2020.173656_bib86","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/gb-2003-4-8-225","article-title":"Angiotensin-I-converting enzyme and its relatives","volume":"4","author":"Riordan","year":"2003","journal-title":"Genome Biol."},{"key":"10.1016\/j.ejphar.2020.173656_bib87","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bph.12318","article-title":"AVE 0991, a non-peptide mimic of angiotensin-(1-7) effects, attenuates pulmonary remodelling in a model of chronic asthma","volume":"170","author":"Rodrigues-Machado","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173656_bib88","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1-7)\/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2020.173656_bib89","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1172\/JCI69608","article-title":"Apelin is a positive regulator of ACE2 in failing hearts","volume":"123","author":"Sato","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2020.173656_bib90","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12985-019-1182-0","article-title":"Coronavirus envelope protein: current knowledge","volume":"16","author":"Schoeman","year":"2019","journal-title":"Virol. J."},{"key":"10.1016\/j.ejphar.2020.173656_bib91","doi-asserted-by":"crossref","first-page":"H1365","DOI":"10.1152\/ajpheart.00608.2009","article-title":"Angiotensin-(1-7) stimulates high atrial pacing-induced ANP secretion via Mas\/PI3-kinase\/Akt axis and Na+\/H+ exchanger","volume":"298","author":"Shah","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2020.173656_bib92","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.173656_bib93","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/SHK.0b013e318189017a","article-title":"Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor kappaB and mitogen-activated protein kinases","volume":"31","author":"Shen","year":"2009","journal-title":"Shock"},{"key":"10.1016\/j.ejphar.2020.173656_bib94","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijid.2020.05.002","article-title":"Urgent need for evaluating agonists of angiotensin-(1-7)\/Mas receptor axis for treating patients with COVID-19","volume":"96","author":"Shete","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ejphar.2020.173656_bib95","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.0306446101","article-title":"Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry","volume":"101","author":"Simmons","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2020.173656_bib96","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.antiviral.2013.09.028","article-title":"Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research","volume":"100","author":"Simmons","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2020.173656_bib97","doi-asserted-by":"crossref","first-page":"L17","DOI":"10.1152\/ajplung.00498.2016","article-title":"Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg(9) bradykinin\/BKB1R axis and facilitates LPS-induced neutrophil infiltration","volume":"314","author":"Sodhi","year":"2018","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ejphar.2020.173656_bib98","article-title":"Rapid response: preventing a Covid-19 pandemic: ACE inhibitors as a potential risk factor for fatal Covid-19","volume":"368 m810","author":"Sommerstein","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2020.173656_bib99","doi-asserted-by":"crossref","first-page":"10328","DOI":"10.1128\/JVI.78.19.10328-10335.2004","article-title":"Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein","volume":"78","author":"Song","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2020.173656_bib100","doi-asserted-by":"crossref","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"South","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2020.173656_bib101","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.coph.2015.01.004","article-title":"Angiotensin type 2 receptors: blood pressure regulation and end organ damage","volume":"21","author":"Sumners","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173656_bib102","first-page":"219","article-title":"[Inhibitors of RAS might Be a good choice for the therapy of COVID-19 pneumonia]","volume":"43","author":"Sun","year":"2020","journal-title":"Zhonghua Jiehe He Huxi Zazhi"},{"key":"10.1016\/j.ejphar.2020.173656_bib103","first-page":"145","article-title":"[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]","volume":"41","year":"2020","journal-title":"Zhonghua Liuxingbingxue Zazhi"},{"key":"10.1016\/j.ejphar.2020.173656_bib104","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/ATVBAHA.110.204453","article-title":"Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice","volume":"30","author":"Tesanovic","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2020.173656_bib105","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1074\/jbc.M113.526210","article-title":"Apelin attenuates oxidative stress in human adipocytes","volume":"289","author":"Than","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.173656_bib106","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.173656_bib107","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2020.173656_bib108","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11906-014-0420-5","article-title":"ACE2: angiotensin II\/angiotensin-(1-7) balance in cardiac and renal injury","volume":"16","author":"Varagic","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.ejphar.2020.173656_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","author":"Verdecchia","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ejphar.2020.173656_bib110","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.173656_bib111","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2020.173656_bib112","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yjmcc.2016.05.012","article-title":"The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice","volume":"97","author":"Wang","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2020.173656_bib113","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s12630-020-01591-x","article-title":"Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients","volume":"67","author":"Wax","year":"2020","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.ejphar.2020.173656_bib114","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.clinthera.2007.09.019","article-title":"Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?","volume":"29","author":"Weir","year":"2007","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173656_bib115","doi-asserted-by":"crossref","first-page":"9313","DOI":"10.1128\/JVI.01237-15","article-title":"A coronavirus E protein is present in two distinct pools with different effects on assembly and the secretory pathway","author":"Westerbeck JW","year":"2015","journal-title":"J. Virol."},{"year":"2003","author":"WHO","series-title":"Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31","key":"10.1016\/j.ejphar.2020.173656_bib116"},{"author":"WHO","key":"10.1016\/j.ejphar.2020.173656_bib118"},{"key":"10.1016\/j.ejphar.2020.173656_bib119","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2020.173656_bib120","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72\u00a0314 cases from the Chinese center for disease control and prevention","author":"Wu","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.ejphar.2020.173656_bib121","first-page":"450","article-title":"Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection","volume":"57","author":"Yang","year":"2007","journal-title":"Comp. Med."},{"key":"10.1016\/j.ejphar.2020.173656_bib122","doi-asserted-by":"crossref","first-page":"102434","DOI":"10.1016\/j.jaut.2020.102434","article-title":"The deadly coronaviruses: the 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China","volume":"109","author":"Yang","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.ejphar.2020.173656_bib123","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jss.2007.03.075","article-title":"Losartan attenuates ventilator-induced lung injury","volume":"145","author":"Yao","year":"2008","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ejphar.2020.173656_bib124","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3904\/kjim.2014.29.3.291","article-title":"The renin-angiotensin system and aging in the kidney","volume":"29","author":"Yoon","year":"2014","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.ejphar.2020.173656_bib125","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6731093","article-title":"Age-associated changes in the vascular renin-angiotensin system in mice","volume":"2016","author":"Yoon","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.ejphar.2020.173656_bib126","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2020.173656_bib127","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s13054-017-1882-z","article-title":"Recombinant human ACE2: acing out angiotensin II in ARDS therapy","volume":"21","author":"Zhang","year":"2017","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejphar.2020.173656_bib128","article-title":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","author":"Zhang","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2020.173656_bib129","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1089\/hum.2009.160","article-title":"ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction","volume":"21","author":"Zhao","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ejphar.2020.173656_bib130","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","article-title":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction","volume":"122","author":"Zhong","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2020.173656_bib131","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.173656_bib132","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3892\/ijmm.2016.2544","article-title":"Apelin\/APJ system: a novel therapeutic target for oxidative stress-related inflammatory diseases (Review)","volume":"37","author":"Zhou","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2020.173656_bib133","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/01.CIR.0000094734.67990.99","article-title":"Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2","volume":"108","author":"Zisman","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2020.173656_bib134","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/01.CIR.0000094733.61689.D4","article-title":"Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on angiotensin II as substrate","volume":"108","author":"Zisman","year":"2003","journal-title":"Circulation"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920307482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920307482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:44:54Z","timestamp":1757976294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920307482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":133,"alternative-id":["S0014299920307482"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173656","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renin-angiotensin system at the interface of COVID-19 infection","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173656","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173656"}}